ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
18 announcements with these filters
Banka BioLoo responded to NSE's query on a significant price movement, stating the spurt was market-driven. The company says it has made all required disclosures and has no pending price-sensitive announcement.
Banka BioLoo Limited has granted 2,000 stock options under its Employees Stock Option Plan 2023. The options are exercisable at face value of Rs.10 per share.
Banka Bio reported FY26 total income of ₹58.4 cr (+7.1% YoY) and a return to profitability with ₹0.39 cr PAT. Strategy focuses on converting Megaliter's asset-light contracted revenues into recurring cash flows.
Banka BioLoo Limited conducted its 14th Annual General Meeting on September 17, 2026. The meeting covered routine business, including financial statement adoption and director re-appointment.
Banka BioLoo Limited has issued the notice for its 14th Annual General Meeting, scheduled to be held on September 17, 2026, via video conferencing.
Banka BioLoo reported strong Q1 FY27 growth with Revenue up 20.5% and PAT surging 162.3% YoY. The company is scaling its water infrastructure portfolio through subsidiary Megaliter Varunaa.
Banka Bioloo Ltd reported revenue from operations of ₹10.6 Cr (-4.5% YoY) and net profit of ₹0 Cr for Q1 FY27.
Banka BioLoo Limited announced the grant of 16,000 options to eligible employees under its existing 2023 Employee Stock Option Plan.
Banka BioLoo Limited has scheduled a board meeting for August 13, 2026. The board will consider and approve unaudited standalone and consolidated quarterly financial results.
Banka BioLoo Limited has fully repaid Rs.4.3 Crore in non-convertible debentures. No amounts remain outstanding on this facility.
Banka BioLoo received NSE approval for listing 9,500 equity shares. These shares were allotted under the company's ESOP.
Banka BioLoo Limited allotted 9,500 equity shares following the exercise of employee stock options. This minor equity expansion supports employee retention and results in a Rs. 0.01 Crore capital inflow.
Banka BioLoo appointed C Srilakshmi Manjula as Company Secretary and SMAB & Associates as Internal Auditors. These management appointments aim to strengthen corporate governance and compliance.
Banka BioLoo reported a decisive turnaround in Q4 FY26, swinging to positive PAT of ₹157.1L (Standalone). Focus remains on WaSH and Railways sanitation solutions with significant order book expansion.
Banka BioLoo Limited updated its authorized Key Managerial Personnel list for materiality determination under SEBI Regulations. This follows the appointment of a new Company Secretary.
Banka Bioloo Ltd reported revenue from operations of ₹17.7 Cr (+19.6% YoY) and net profit of ₹1.6 Cr for Q4 FY26.
Banka BioLoo Limited reported standalone annual total income of ₹61.01 Crore for FY26. The board also appointed Ms. Srilakshmi Manjula Chaitanya Chunduru as Company Secretary.
Banka BioLoo scheduled a board meeting for May 26, 2026, to approve audited annual financial results. The trading window remains closed until May 28, 2026.